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The increased incidence and severity of Clostridium difficile
infection (CDI) in older adults (age, 65 years) corresponds
with the emergence of the BI/NAP1 strain, making eluci-
dation of the host immune response extremely important.
We therefore infected germ-free C57BL/6 mice aged 7–14
months with a BI/NAP1 strain and monitored the mice for
response. Infected mice were moribund 48–72 h after infec-
tion and developed gross and histological cecitis and colitis
and elevated concentrations of keratinocyte chemoattractant,
interleukin 1b, monocyte chemotactic protein 1, and gran-
ulocyte colony-stimulating factor and decreased levels of in-
terferon g, interleukin 12 p40, interleukin 12 p70, and in-
terleukin 10 compared with controls. We conclude that aged,
germ-free C57BL/6 mice are susceptible to fulminant CDI
from a BI/NAP1 strain and represent a novel model to fur-
ther elucidate the host immune response to acute CDI.
The incidence, severity, and mortality of Clostridium difficile
infection (CDI) have increased, especially in individuals 65
years of age, possibly in association with the emergence of the
epidemic restriction endonuclease analysis and pulse field gel
electrophoresis BI/NAP1 strain [1]. This strain has been present
since the 1980s but was not previously responsible for outbreaks
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[2]. It hyperproduces toxins A and B, secretes a binary toxin,
hypersporulates, and has developed high-level fluoroquinolone
resistance, which suggests that these traits have led to increased
virulence and spread [2].
A murine model of infection is extremely important to help
elucidate the host immune response to CDI and to better un-
derstand the pathogenesis induced by BI/NAP1 as well as ad-
ditional C. difficile strains. The traditional animal model of CDI,
the Syrian hamster, is limited by an inability to study the host
cytokine response due to a lack of host-specific reagents. Pre-
vious germ-free CDI experiments with murine strains other
than C57BL/6, particularly in the 1980s and early 1990s, re-
sulted in minimal intestinal pathogenesis to severe cecal and
colon ulceration with 100% mortality [3, 4]. The majority of
these studies, however, utilized a highly toxigenic laboratory
strain, VPI 10463, which has high levels of toxin A and B
production, has low sporulation rates, and has never been
found to cause human colitis. No gnotobiotic murine studies
have been performed with the BI/NAP1 strain, and it has not
yet been determined whether germ-free C57BL/6 mice are sus-
ceptible to CDI. Additionally, the murine mucosal cytokine
response to CDI has not been documented.
Therefore, we undertook this study to determine whether
germ-free C57BL/6 mice—a commonly investigated strain that
can be bred for transgenic and knockout mouse studies—in-
oculated with a clinically relevant BI/NAP1 strain could be a
beneficial model to study the pathogenesis of and host mucosal
cytokine responses to acute CDI.
Methods. UVA13, a human-infecting C. difficile isolate that
was previously cultured from a fecal specimen from a patient
with CDI at the University of Virginia Hospital and typed as
BI/NAP1 by the Hines Reference Laboratory at the Hines Vet-
erans Affairs Hospital (Hines, IL) with the use of restriction
endonuclease analysis and a protocol that has been described
elsewhere [5], was inoculated into chopped meat broth and
incubated anaerobically at 38C for 24 h. Sixteen germ-free
C57BL/6 mice (age, 7–14 months) from the National Gnoto-
biotic Rodent Resource Center at the University of North Car-
olina were orally gavaged with 330 mL of incubated broth con-
taining a total of organisms. Similarly, VPI 11186, a81  10
nontoxigenic strain of C. difficile, was incubated in broth for
24 h, and 2 germ-free mice were orally gavaged with 81  10
organisms. Six germ-free mice received a similar dosage of
uninoculated broth and served as uninfected controls. Sterility
was confirmed in germ-free mice by aerobic and anaerobic
BRIEF REPORT • JID 2010:202 (1 December) • 1709
culture and Gram staining of stool samples, as outlined else-
where [6].
Mice were monitored every 8 h after inoculation for clinical
signs and symptoms of disease, including diarrhea and impaired
physical condition and behavior. Weights were obtained as a
measure of disease at the time of euthanasia. Mice that were
determined to be moribund according to Animal Care and Use
Committee policy and approved protocol were weighed and
euthanized. (See Appendix 1, which appears only in the online
version of the Journal.)
Cecal and colon segments were collected from euthanized
mice and prepared for histological analysis by use of hema-
toxylin-eosin stain and antibodies directed against myelo-
peroxidase. Histological specimens were scored by 2 blinded
investigators (S.W.P. and R.F.) on a scale of 0–3 (minimal
score, 0; maximal score, 3) on the basis of each of the follow-
ing criteria: inflammatory cell infiltration, mucosal hypertro-
phy, vascular congestion, epithelial disruption, and submuco-
sal edema. (See Appendix 2, which appears only in the online
version of the Journal.)
Cecal and colon segments were homogenized and assayed
for the cytokines granulocyte colony-stimulating factor (G-
CSF), interleukin 1b (IL-1b), keratinocyte chemoattractant
(KC), tumor necrosis factor a (TNF-a), interferon g (IFN-g),
monocyte chemotactic protein 1 (MCP-1), interleukin 12 p40
(IL-12p40), interleukin 12 p70 (IL-12p70), interleukin 6 (IL-
6), interleukin 17 (IL-17), interleukin 13 (IL-13), and inter-
leukin 10 (IL-10) by use of bead-based Luminex immunoan-
alysis (Bio-Rad).
Mean differences in cecal and colon histopathological scores
and cytokine levels were analyzed with SPSS software (version
17; SPSS) and evaluated using an independent Student t test.
Results for which were determined to be significant.P  .05
Results. All mice given UVA13 died or were moribund (ne-
cessitating euthanasia) within 72 h, whereas mice given VPI
11186 or broth were asymptomatic. Germ-free mice admin-
istered UVA13 developed diarrhea and/or wet tail, accompanied
by weight loss. Eleven (69%) of 16 UVA13-infected mice were
euthanized and processed for histological and cytokine analysis
(5 UVA13-infected mice died and could not be processed).
Broth control mice ( ) and mice infected with the non-N p 6
toxigenic strain ( ) were euthanized after 72 h, processed,N p 2
and assessed for comparison of histological scores and cytokine
levels.
In a gross comparison, UVA13-infected mice had shorter
ceca than those of controls, with evidence of purulent, hem-
orrhagic, or loose cecal contents with less pronounced altera-
tions in colon segments. Histopathological scores were signif-
icantly higher in UVA13-infected mice than in control mice,
with evidence of both cecal and colon ulceration, loss of mu-
cosal architecture, epithelial exfoliation, inflammatory cell in-
filtration, edema, and hemorrhage in the lamina propria (Figure
1). Although neutrophilic infiltration was demonstrated with
myeloperoxidase staining, it was relatively minor, and there was
evidence of myeloperoxidase both within neutrophils and ex-
travasated within the lumen (Figure 1).
We next examined cecal and colon segments to determine
mucosal cytokine concentrations produced after infection.
UVA13 infection led to elevated cecal and colonic concentra-
tions of KC, MCP-1, IL-1b, and G-CSF compared with those
in controls; concentrations were greater in the cecum than in
the colon (Figure 2). Additionally, BI/NAP1 infection led to
lower levels of cecal and colonic IL-12p40, IL-12p70, IFN-g,
and IL-10 (Figure 2). There were no differences in the con-
centrations of the pro-inflammatory cytokines TNF-a, IL-6,
IL-13, and IL-17.
Discussion. The results of this study indicate that acute
infection with a clinically relevant BI/NAP1 C. difficile strain
leads to weight loss, symptomatic disease, cecal and colonic
ulceration, a relatively minor neutrophil infiltration, a mea-
surable cytokine response, and eventual death in monoasso-
ciated C57BL/6 mice. The clinical and histopathological find-
ings are in agreement with those of Vernet and colleagues [4],
who previously observed that germ-free C3H/He mice infected
with C. difficile that secreted elevated levels of toxin A in vitro
developed cecal and colon ulceration and 100% mortality. The
findings of other studies demonstrate that the BI/NAP1 strain
hyperproduces toxins A and B in vitro, and those of additional
studies, as well as of work in our laboratory, indicate that VPI
10463, which was used in the majority of previous studies
involving CDI in germ-free mice, produces even greater levels
of toxin A in vitro compared with UVA13 [2].
Previous studies of the host cytokine response to toxins A
and B have been limited to data from cell culture and small
intestinal loops directly exposed to purified toxins A or B, and
those studies have shown a predominant inflammatory re-
sponse to toxin exposure. Binding of the toxins to their re-
spective receptor leads to induction of mitogen-activated pro-
tein kinase, translocation of nuclear factor kB into the nucleus,
inhibition of the Rho family of proteins, and activation of
submucosal neurons, all of which have the effect of activation
of pro-inflammatory cytokines, recruitment of neutrophils, ep-
ithelial cell apoptosis, and disruption of tight junctions. Not
only does toxin exposure lead to the secretion of some pro-
inflammatory cytokines, it may also lead to decreased levels of
protective cytokines such as transforming growth factor b
(TGF-b) [7]. We demonstrated increased production of many,
but not all, proinflammatory cytokines produced by innate
immune cells and epithelial cells, as well as decreased mucosal
production of IL-10, another protective cytokine. We did not
measure TGF-b concentrations.
The elevations of IL-1b, KC (human interleukin 8 [IL-8]
1710 • JID 2010:202 (1 December) • BRIEF REPORT
Figure 1. Histopathological analysis of cecal and colon segments 72 h after oral inoculation with colony-forming units of UVA13 (BI/NAP181  10
[BI] strain of Clostridium difficile), VPI 11186 (nontoxigenic C. difficile strain), or broth. A, Hematoxylin-eosin stain of a cecal segment from a germ-
free mouse infected with the nontoxigenic strain. B, Hematoxylin-eosin stain of a cecal segment from a germ-free mouse infected with the BI strain.
C, Myeloperoxidase stain of a cecal segment from a germ-free mouse infected with the BI strain (brown indicates myeloperoxidase activity). D,
Histopathological differences in the cecum and colon between BI-infected mice ( ), mice infected with the nontoxigenic strain ( ), andN p 11 N p 2
broth controls ( ) as determined by inflammatory cell infiltration, mucosal hypertrophy, vascular congestion, epithelial disruption, and submucosalN p 6
edema, with a maximum score of 15. * for BI-infected mice compared with broth controls. L, lumen.P  .001
equivalent), and MCP-1 in our study of BI/NAP1 CDI are in
agreement with the findings of cell culture and murine intestinal
loop studies that show elevations in the same cytokines in
response to toxin exposure. Our results are also in agreement
with cytokine data in studies of CDI in humans, which show
elevated fecal IL-8 levels in patients with clinically severe CDI
[8]. Similarly, decreased levels of IL-10, which are normally
thought to play a role in maintaining the host barrier defense
and suppressing inflammation, in our BI/NAP1-infected mice
are in agreement with our preliminary data from rabbit intes-
tinal loops showing decreased IL-10 levels after toxin A ex-
posure (C.A.W., oral communication, April 2010). These sim-
ilarities of cytotoxic profiles further validate the clinical rele-
vance of our model.
Interestingly, there was no difference in the pro-inflamma-
tory cytokine TNF-a, which has previously been shown to be
increased in toxin A enteritis [9]. In addition, the significantly
lower levels of IFN-g in our severely infected mice are in con-
trast to those found in studies of small intestinal loops exposed
to purified toxin A by Ishida and colleagues [9], who hypoth-
esized that IFN-g is the crucial mediator of toxin-induced en-
teritis after noting attenuated disease in IFN-g knockout mice.
The interrelationship among cytokines likely explains the low
levels of TNF-a, as IFN-g is partially responsible for TNF-a
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Figure 2. Cytokine concentrations in the cecum and colon 72 h after
oral inoculation with colony-forming units of UVA13 (BI/NAP1 [BI]81  10
strain of Clostridium difficile), VPI 11186 (nontoxigenic strain), or broth.
Cecal (A) and colon (B) segments were homogenized in a proteinase inhibitor
cocktail and assayed for the cytokines granulocyte colony-stimulating factor
(G-CSF), monocyte chemotactic protein 1 (MCP-1), keratinocyte chemoat-
tractant (KC), interleukin 1b (IL-1b), interleukin 12 p40 (IL-12p40), interleukin
12 p70 (IL-12p70), interferon g (IFN-g), interleukin 10 (IL-10), tumor necrosis
factor a (TNF-a), interleukin 6 (IL-6), interleukin 17 (IL-17), and interleukin
13 (IL-13) by use of Luminex immunoanalysis (Bio-Rad). There were no
significant differences in IL-6, IL-17, or IL-13 concentrations between the
groups (data not shown). * for BI–infected mice ( ) comparedP  .05 N p 11
with broth controls ( ); ** for BI-infected mice ( )N p 6 P  .001 N p 11
compared with broth controls ( ).N p 6
expression in murine intestinal loops exposed to toxin A [9].
Additionally, IL-12, which was significantly lower in our BI/
NAP1-infected mice, has been shown to induce IFN-g expres-
sion in macrophages, T cells, and intestinal loops and therefore
may be partially responsible for the low levels of IFN- g found
[9–11].
The differences in cytokine expression between our model
of CDI and studies involving pure toxin exposure of cell culture
and intestinal loops may in part be due to a lack of direct host-
pathogen interaction in the latter models. Toxin A–negative,
toxin B–positive C. difficile strains lead to severe human CDI
despite the limited pathogenesis observed when purified toxin
B is inoculated into murine, hamster, and rabbit small intestinal
loops [5]. On the other hand, purified toxin A within murine,
hamster, and rabbit small intestinal loops leads to severe dis-
ease. Further lending credence to the importance of the patho-
gen-host interaction is a recent study indicating that toxin B
is responsible for pathogenesis as opposed to toxin A. In this
study, Lyras and colleagues [12] found that hamsters exposed
to a toxin A–positive, toxin B–negative C. difficile showed no
evidence of disease, whereas disease was observed in hamsters
exposed to a toxin A–negative, toxin B–positive variant. Ad-
ditionally, C. difficile surface layer proteins lead to pro-inflam-
matory IL-1b and IL-6 secretion, which highlights the impor-
tance of host-pathogen recognition and signaling and the inter-
action of the toxin and the C. difficile–derived components [13].
While we were performing our germ-free studies, Chen and
colleagues [14] discovered a murine model of CDI using con-
ventional C57BL/6 mice, which leads to ulcerative cecitis, co-
litis, and a moribund state after exposure to 6 antibiotics and
VPI 10463, whereas a BI/NAP1 strain given in a similar manner
leads to symptomatic disease and cecal and colon pathogenesis,
but no mortality. Histological analysis of the cecum and colon
of BI/NAP1–infected mice in the study by Chen and colleagues
[14] demonstrated subcutaneous edema and neutrophilic in-
filtration but little epithelial disruption, whereas mice given VPI
10463 showed destruction of the host architecture in addition
to edema and neutrophil margination, indicating that epithelial
disruption is necessary to induce mortality, which is similar to
the results found for gnotobiotic mice [4, 14]. Why the BI/
NAP1 strain was able to induce epithelial destruction and death
in our monoassociated mice, as opposed to in the conventional
mice in the study by Chen and colleagues [14], is unknown,
but possibilities include the greater number of organisms used
to colonize our mice ( vs colony-forming units),8 51  10 1  10
age-related differences in the host immune response, less de-
veloped mucosal responses in germ-free mice, or an influence
by the retained host microbiota after antibiotics [15]. While
microbiota analysis was not performed on fecal pellets before
or after exposure to antibiotics, one can hypothesize that ex-
posure to 6 different antibiotics led to decreased normal bac-
terial concentrations and altered composition, although anti-
biotics do not induce a sterile state.
We have thus shown that BI/NAP1 CDI in an aged germ-
free C57BL/6 mouse leads to symptomatic disease, a mori-
bund state, and profound histopathology in the cecum and colon.
Additionally, as a result of CDI, certain cecal and colonic cyto-
kines are produced, which had not previously been documented.
Differences in cytokine production between in vivo infection and
small intestinal loop studies or in vitro toxin studies highlight
the importance of the host-pathogen relationship in CDI. Use
of this model in concurrence with other newly established con-
ventional C57BL/6 mouse models will lead to a greater under-
standing of the host-pathogen interaction and the role of the
host microbiota in CDI.
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